Pathological attention-seeking behavior, on the other hand, is characterized by: Persistent and compulsive Serious impairment of social and professional functioning Inability to control impulses Extreme distress at not receiving the desired attention Willingness to take extreme measures to get attention Associated Mental Health Disorders Excessive attention-seeking can be a symptom of a variety of mental disorders: Histrionic personality disorder
GLP-1 Shot is a prescribed injection
There was this side effect
Current Coverage Statistics: Approximately 31% of Canadian employers now provide coverage for GLP-1 medications for both diabetes and weight loss applications However, 56% of employers still limit coverage to diabetes-only use Fewer than 20% of private drug plans cover anti-obesity medications at all What to Expect with Private Coverage: If your private insurance includes semaglutide, most plans cover 50-80% of the medication cost, with co-payments typically ranging from $106 to several hundred dollars monthly
Additionally, due to individual variability and differences in developmental stages, the response to the medication may differ from that observed in adults, making it difficult to extrapolate the results of short-term studies to long-term usage scenarios
